HBV-IN-52

Description

HBV-IN-52 is a selective HBV inhibitor. HBV-IN-52 is a Neplanocin A HY-130430 derivative that demonstrates significant activity against HBV replication with EC50 = 0.96 ?M. HBV-IN-52 can inhibit HBsAg secretion EC50 = 0.82 ?M. HBV-IN-52 can be studied in research for chronic hepatitis B CHB infections.